Search

everythinglearnresearchcommunity

for

Search:↓

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata patients have higher osteopontin levels and more eye changes, but their vision remains unaffected.

Balding men have harder scalps.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.

Alopecia areata may lead to hearing loss.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Lower hardiness and resilience in mixed alopecia patients may predict more psychological distress.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Alopecia areata treatments often don't lead to lasting improvement.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Men with alopecia areata tend to have larger limb and trunk circumferences than healthy men.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

People with alopecia areata have more inflammation but similar heart risk as healthy people.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.